Eslo 5 Tablet contains S-Amlodipine 5 mg, a calcium channel blocker used primarily in the management of hypertension and angina pectoris. S-Amlodipine, the pharmacologically active enantiomer of amlodipine, exerts its therapeutic effect by inhibiting the influx of calcium ions through L-type calcium channels in vascular smooth muscle and cardiac muscle cells. This action results in vasodilation of peripheral arteries, leading to a reduction in systemic vascular resistance and blood pressure. Eslo 5 is indicated for the treatment of essential hypertension, helping to prevent complications such as stroke, myocardial infarction, and renal impairment. Additionally, it is effective in the management of chronic stable angina and vasospastic angina by improving myocardial oxygen supply-demand balance. The tablet is typically administered once daily, with dosage adjustments based on clinical response and tolerability. Common adverse effects may include peripheral edema, headache, dizziness, and fatigue, while serious side effects are rare but warrant immediate medical attention. Eslo 5 should be used cautiously in patients with severe hepatic impairment and is contraindicated in individuals with known hypersensitivity to amlodipine or other dihydropyridine calcium channel blockers. Regular monitoring of blood pressure and clinical status is recommended to ensure optimal therapeutic outcomes.